Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Zhong Ji Longevity Science Group Days Payable?
Zhong Ji Longevity Science GroupHKSE:00767 -5.26%55 Days Payable is 47.73 as of Dec. 2025, which is 41% below its 10-year median of 80.52. GuruFocus rates HKSE:00767 with a GF Score™ of 55/100 and a GF Value™ of HK$0.89 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 190 Medical Diagnostics & Research companies, Zhong Ji Longevity Science Group ranks better than 67.37% on this metric.
The historical rank and industry rank for Zhong Ji Longevity Science Group's Days Payable or its related term are showing as below:
HKSE:00767'
s Days Payable Range Over the Past 10 Years
Min: 10.07 Med: 80.52 Max: 10266.27
Current: 112.26
During the past 13 years, Zhong Ji Longevity Science Group's highest Days Payable was 10266.27. The lowest was 10.07. And the median was 80.52.
HKSE:00767's Days Payable is ranked better than 67.37% of 190
companies
in the Medical Diagnostics & Research industry
Industry Median: 64.64
vs HKSE:00767: 112.26
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhong Ji Longevity Science Group Days Payable Chart
HKSE:00767 vs TMO, DHR, IDXX: Days Payable Comparison
For the Diagnostics & Research subindustry, Zhong Ji Longevity Science Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhong Ji Longevity Science Group Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Zhong Ji Longevity Science Group's Days Payable distribution charts can be found below:
* The bar in red indicates where Zhong Ji Longevity Science Group's Days Payable falls into.
Zhong Ji Longevity Science Group Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhong Ji Longevity Science Group (HKSE:00767) has a Days Payable of 47.73 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zhong Ji Longevity Science Group and its competitors. This is 41% below median its historical median of 80.52. Over the past decade, Zhong Ji Longevity Science Group's Days Payable has ranged from 10.07 to 10,266.27. According to the industry distribution chart, Zhong Ji Longevity Science Group ranks #62 out of 190 companies in the Medical Diagnostics & Research industry, placing it in the top 32.6%.
Is Zhong Ji Longevity Science Group's Days Payable too high?
Zhong Ji Longevity Science Group's current Days Payable of 47.73 is 41% below median its 10-year median of 80.52. Over the past 10 years, this metric has ranged from a low of 10.07 to a high of 10,266.27. The Medical Diagnostics & Research industry median Days Payable is 64.64. Zhong Ji Longevity Science Group's value of 47.73 is 26.2% below this industry median. Based on the distribution chart, Zhong Ji Longevity Science Group ranks #62 out of 190 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Zhong Ji Longevity Science Group has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Zhong Ji Longevity Science Group's Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Zhong Ji Longevity Science Group ranks #62 out of 190 companies for Days Payable. This puts Zhong Ji Longevity Science Group in the upper half of its industry. The industry median Days Payable is 64.64. Zhong Ji Longevity Science Group's value of 47.73 is 26.2% below this benchmark. Historically, Zhong Ji Longevity Science Group's own Days Payable has ranged from 10.07 to 10,266.27 over the past decade. While the company's 10-year median is 80.52 vs. the industry median of 64.64, Zhong Ji Longevity Science Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 64.64, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhong Ji Longevity Science Group's current Days Payable of 47.73 is 26.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zhong Ji Longevity Science Group and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 64.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhong Ji Longevity Science Group's current Days Payable is 47.73, which is 41% below median its own 10-year median of 80.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhong Ji Longevity Science Group stock overvalued right now?
Based on GuruFocus' analysis, Zhong Ji Longevity Science Group (HKSE:00767) is currently considered Possible Value Trap. The stock's GF Value™ is HK$0.89, compared to a current price of HK$0.36 — trading 59.6% below its estimated fair value. The current Days Payable is 47.73, which is 41% below median its 10-year median of 80.52 and 26.2% below the Medical Diagnostics & Research industry median of 64.64. Zhong Ji Longevity Science Group's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Zhong Ji Longevity Science Group (HKSE:00767), the current Days Payable is 47.73 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhong Ji Longevity Science Group (HKSE:00767) Overvalued in 2026?
Based on GuruFocus' analysis, Zhong Ji Longevity Science Group stock appears to be undervalued.
The current stock price of HK$0.36 is trading 59.6% below its estimated GF Value™ of HK$0.89.
GuruFocus considers Zhong Ji Longevity Science Group to be Possible Value Trap.
Key valuation signals for HKSE:00767:
Days Payable: 47.73 (41% below median its 10-year median of 80.52)
GF Value™: HK$0.89 vs. price of HK$0.36 (59.6% below fair value)
Industry Position: 26.2% below the Medical Diagnostics & Research median (#62 of 190)
No single metric tells the full story. See the HKSE:00767 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhong Ji Longevity Science Group Ltd is an investment holding company. Through its subsidiaries, it engages in Longevity science business, Money lending and Financial Advisory, Securities and other investments, and Property investment. The company generates the majority of its revenue from the Longevity Science business. The Longevity science business includes the provision of diagnostic consultation, health and medical testing and checking, distribution of cancer prevention & immunity healthcare supplements, and the sales and distribution of longevity wine.
55GF Score
Get the complete analysis for HKSE:00767
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00767 has been successfully added to your 
